Management Team

• Jonathan Smith, Ph.D., Chief Scientific Officer
  
  Dr. Jonathan Smith is one of our original founding scientists and chairs our Science Advisory Board. For many years, Dr. Smith served as Chief of the Department of Viral Biology at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). He has been a leader in the development of genetically engineered, live attenuated vaccines for several viruses and the generation of new generic vaccine vectors based on alphavirus RNA replicons. Dr. Smith is a graduate of Colby College and the University of Texas at Austin, where he earned his Ph.D. in microbiology and virology, and has completed postdoctoral training at the Institute of Genetics in Cologne, Germany.
• Robert Olmsted, Ph.D., VP Research
  
  Dr. Robert Olmsted was most recently the leader of the RNA Virus Antiviral Program Team at Pharmacia & Upjohn, where he initiated and headed the antiviral drug discovery effort for the hepatitis C virus. While a research assistant professor at Georgetown University, he led an effort to develop a feline model for AIDS (feline immunodeficiency virus). Dr. Olmsted graduated from Alfred University and North Carolina State University and conducted postdoctoral research in the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), a division of NIH.
• Janice Kimpel, Ph.D., VP Business Development
  
  Dr. Janice Kimpel became familiar with our technology and patent family while working as Science Advisor and Patent Agent for our external patent counsel. She has also worked as the Director of Technology Licensing at the University of Georgia, where she was responsible for licensing diverse technologies including pharmaceuticals, veterinary vaccines, and recombinant DNA discoveries. She earned her Ph.D. from the University of California, Davis.
• Andrew Graham, M.S., VP Development & Technical Operations
  
  Andrew Graham joined our team in 2004 from Aventis Pasteur, where he worked for 16 years and was most recently Senior Director of Industrialization for the company's vaccine operations. Mr. Graham, a Canadian citizen, received his undergraduate degree in biochemistry from McGill University in Montreal and a master's degree in chemical engineering from the University of Waterloo in Ontario. He has more than 20 years of experience in academia and industry working on the complex biological processes of vaccine development.
   
  
• Tim Gupton, CPA, CFO
  
  Tim Gupton is a senior partner at Hughes, Pittman & Gupton, LLP, a public accounting firm in Raleigh, North Carolina, and is a general partner with Research Triangle Ventures. As our CFO, he is responsible for strategic financial planning, financial reporting to investors and management, internal controls, cash forecasting, acquisition of equity, and debt financing. Previously, Mr. Gupton was a partner with KPMG Peat Marwick and has co-founded and served as start-up CFO for several biotechnology companies, including Trimeris, Inc., Inspire Pharmaceuticals, and SARCO, Inc. Mr. Gupton is a graduate of the University of North Carolina at Chapel Hill.